December 15, 20215:17 PM UTCLast Updated ago

U.S. RESEARCH ROUNDUP Azek Company, Galera Therapeutics, Vivint Smart Home

1 minute read

Register now for FREE unlimited access to Reuters.com

Dec 15 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Azek Company, Galera Therapeutics and Vivint Smart Home, on Wednesday.

HIGHLIGHTS

Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.

Register now for FREE unlimited access to Reuters.com

Compiled by Bengaluru Newsroom

Our Standards: The Thomson Reuters Trust Principles.

Funds

Vanguard to pay millions to mutual fund investors hit with big tax bills, article with galleryLegal · July 6, 2022
Vanguard Group, the largest mutual fund company, on Wednesday reached a $6.25 million settlement to resolve regulatory charges it failed to warn many fund investors that they would face surprisingly big tax bills.
U.S. MarketsU.S. SEC to vote on July 13 to adopt proxy rules that undo Trump-era condition, article with galleryJuly 6, 2022
Future of MoneyCrypto exchange FTX has "a few billion" to support industry - Bankman-Fried, article with imageJuly 6, 2022
BusinessEDF shares rise after French PM says state will nationalise company, article with galleryJuly 6, 2022
FundsSequoia China raises $9 billion amid hopes crackdown is easing -source, article with imageJuly 6, 2022

U.S. RESEARCH ROUNDUP Azek Company, Galera Therapeutics, Vivint Smart Home

Register now for FREE unlimited access to Reuters.com

Register now for FREE unlimited access to Reuters.com

Funds

Thomson Reuters Products

Refinitiv Products